Article
Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity
31 Jan 2021
Abstract excerpt
In the last decade, we have witnessed an unprecedented clinical success in cancer immunotherapies targeting the programmed cell-death ligand 1 (PD-L1) and programmed cell-death 1 (PD-1) pathway. Besides the fact that PD-L1 plays a key role in immune regulation in tumor microenvironment, recently a plethora of reports has suggested a new perspective of non-immunological functions of PD-L1 in the regulation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
